Human adenovirus type 5 vectors expressing rabies glycoprotein
- 1 September 1996
- Vol. 14 (13) , 1257-1264
- https://doi.org/10.1016/s0264-410x(96)00012-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virusVaccine, 1994
- Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporterVirus Research, 1993
- Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccineArchiv für die gesamte Virusforschung, 1992
- Rabies Virus-specific Human T Cell Clones Provide Help for an in vitro Antibody Response against Neutralizing Antibody-inducing Determinants of the Viral GlycoproteinJournal of General Virology, 1989
- Vaccinia virus: a suitable vehicle for recombinant vaccines?Archiv für die gesamte Virusforschung, 1989
- Antigenic Sites on the CVS Rabies Virus Glycoprotein: Analysis with Monoclonal AntibodiesJournal of General Virology, 1983
- Controls of RNA splicing and termination in the major late adenovirus transcription unitNature, 1981
- Transcripts from the adenovirus-2 major late promoter yield a single early family of 3′ coterminal mRNAs and five late familiesCell, 1980
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977
- Human cell culture rabies vaccine. Antibody response in manPublished by American Medical Association (AMA) ,1973